Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tumor Suppressor Protein p53 | 163 | 2024 | 3671 | 14.900 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 74 | 2022 | 529 | 8.680 |
Why?
|
Proto-Oncogene Proteins | 58 | 2021 | 2624 | 6.010 |
Why?
|
Genes, p53 | 47 | 2023 | 1146 | 5.060 |
Why?
|
Nuclear Proteins | 54 | 2022 | 3472 | 3.950 |
Why?
|
Ubiquitin-Protein Ligases | 27 | 2022 | 882 | 3.240 |
Why?
|
Mice | 172 | 2024 | 36056 | 2.690 |
Why?
|
Li-Fraumeni Syndrome | 15 | 2023 | 167 | 2.560 |
Why?
|
Carcinogenesis | 12 | 2024 | 1037 | 2.240 |
Why?
|
Animals | 198 | 2024 | 62827 | 2.200 |
Why?
|
Neoplasms, Experimental | 11 | 2018 | 790 | 2.120 |
Why?
|
Osteosarcoma | 8 | 2023 | 948 | 2.050 |
Why?
|
Apoptosis | 49 | 2022 | 7837 | 1.950 |
Why?
|
Mutation | 59 | 2024 | 15944 | 1.910 |
Why?
|
Mutation, Missense | 16 | 2024 | 1197 | 1.720 |
Why?
|
Gene Expression Regulation, Neoplastic | 32 | 2024 | 9101 | 1.640 |
Why?
|
Cell Transformation, Neoplastic | 22 | 2024 | 2472 | 1.520 |
Why?
|
Disease Models, Animal | 28 | 2024 | 7476 | 1.410 |
Why?
|
Transcriptional Activation | 18 | 2023 | 1146 | 1.350 |
Why?
|
Triple Negative Breast Neoplasms | 5 | 2024 | 1381 | 1.340 |
Why?
|
Mice, Transgenic | 39 | 2024 | 4371 | 1.320 |
Why?
|
Mice, Knockout | 35 | 2024 | 5841 | 1.310 |
Why?
|
Tumor Suppressor Proteins | 14 | 2015 | 1905 | 1.310 |
Why?
|
Gain of Function Mutation | 2 | 2022 | 134 | 1.300 |
Why?
|
Neoplasms | 34 | 2019 | 15930 | 1.240 |
Why?
|
Neuroendocrine Tumors | 4 | 2022 | 653 | 1.100 |
Why?
|
Pancreatic Neoplasms | 8 | 2024 | 5248 | 1.050 |
Why?
|
Fibroblasts | 13 | 2022 | 1670 | 1.050 |
Why?
|
Bone Neoplasms | 8 | 2023 | 2669 | 1.040 |
Why?
|
Mice, Inbred C57BL | 42 | 2024 | 7238 | 1.030 |
Why?
|
Transcription Factors | 20 | 2023 | 5506 | 1.010 |
Why?
|
Gene Expression Regulation | 24 | 2020 | 4200 | 1.010 |
Why?
|
Mammary Neoplasms, Animal | 3 | 2024 | 238 | 1.000 |
Why?
|
Organ Specificity | 5 | 2023 | 755 | 0.980 |
Why?
|
Transcriptome | 3 | 2024 | 1950 | 0.980 |
Why?
|
Mammary Neoplasms, Experimental | 4 | 2024 | 557 | 0.980 |
Why?
|
Cell Cycle | 21 | 2015 | 2150 | 0.970 |
Why?
|
DNA-Binding Proteins | 18 | 2020 | 5067 | 0.930 |
Why?
|
DNA Damage | 19 | 2017 | 1989 | 0.900 |
Why?
|
Cell Cycle Proteins | 17 | 2021 | 2129 | 0.900 |
Why?
|
Ribonuclease III | 3 | 2019 | 188 | 0.890 |
Why?
|
DEAD-box RNA Helicases | 3 | 2019 | 263 | 0.850 |
Why?
|
Signal Transduction | 27 | 2024 | 12223 | 0.820 |
Why?
|
Embryonic Development | 5 | 2023 | 315 | 0.770 |
Why?
|
Endogenous Retroviruses | 2 | 2020 | 43 | 0.760 |
Why?
|
Carrier Proteins | 5 | 2021 | 2139 | 0.750 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1409 | 0.710 |
Why?
|
Pancreas, Exocrine | 1 | 2020 | 23 | 0.700 |
Why?
|
Ultraviolet Rays | 13 | 2017 | 591 | 0.700 |
Why?
|
Non-alcoholic Fatty Liver Disease | 2 | 2023 | 441 | 0.700 |
Why?
|
Sarcoma, Experimental | 3 | 2009 | 68 | 0.700 |
Why?
|
Cell Line, Tumor | 28 | 2024 | 14881 | 0.680 |
Why?
|
Liver Neoplasms | 6 | 2023 | 4811 | 0.680 |
Why?
|
Radiation, Ionizing | 3 | 2019 | 192 | 0.670 |
Why?
|
Embryo, Mammalian | 14 | 2018 | 758 | 0.670 |
Why?
|
Aging | 7 | 2018 | 1578 | 0.670 |
Why?
|
Genetic Predisposition to Disease | 15 | 2021 | 5756 | 0.660 |
Why?
|
Phenotype | 21 | 2017 | 6517 | 0.660 |
Why?
|
Lymphoma | 5 | 2017 | 1514 | 0.650 |
Why?
|
Intracellular Signaling Peptides and Proteins | 5 | 2024 | 1295 | 0.650 |
Why?
|
Humans | 143 | 2024 | 272091 | 0.650 |
Why?
|
Cell Biology | 1 | 2018 | 17 | 0.640 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2014 | 599 | 0.640 |
Why?
|
Base Pair Mismatch | 1 | 2018 | 82 | 0.640 |
Why?
|
Carcinoma in Situ | 1 | 2022 | 496 | 0.630 |
Why?
|
Alleles | 15 | 2023 | 2599 | 0.630 |
Why?
|
E2F6 Transcription Factor | 1 | 2017 | 10 | 0.600 |
Why?
|
Proto-Oncogene Protein c-ets-2 | 1 | 2017 | 21 | 0.600 |
Why?
|
Genes, Lethal | 7 | 2006 | 132 | 0.590 |
Why?
|
RNA, Small Nucleolar | 1 | 2017 | 26 | 0.590 |
Why?
|
Retinoids | 1 | 2018 | 151 | 0.580 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 695 | 0.580 |
Why?
|
Pancreatitis | 1 | 2020 | 293 | 0.570 |
Why?
|
Single-Cell Analysis | 2 | 2021 | 550 | 0.570 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 11 | 2013 | 541 | 0.550 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 326 | 0.540 |
Why?
|
Tamoxifen | 2 | 2018 | 906 | 0.540 |
Why?
|
Germ-Line Mutation | 10 | 2021 | 1102 | 0.540 |
Why?
|
Gene Editing | 1 | 2018 | 231 | 0.530 |
Why?
|
Transcription, Genetic | 19 | 2014 | 3417 | 0.530 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 1720 | 0.530 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2022 | 1237 | 0.500 |
Why?
|
Hematopoietic Stem Cells | 4 | 2013 | 1373 | 0.500 |
Why?
|
Ubiquitin | 4 | 2014 | 335 | 0.500 |
Why?
|
CRISPR-Cas Systems | 1 | 2018 | 353 | 0.500 |
Why?
|
Genetic Heterogeneity | 3 | 2018 | 327 | 0.490 |
Why?
|
Promoter Regions, Genetic | 21 | 2014 | 3262 | 0.490 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2021 | 1825 | 0.490 |
Why?
|
Homeostasis | 1 | 2020 | 959 | 0.480 |
Why?
|
Protein Processing, Post-Translational | 3 | 2008 | 815 | 0.480 |
Why?
|
Oxygen Consumption | 2 | 2014 | 423 | 0.480 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2014 | 20 | 0.480 |
Why?
|
Ubiquitination | 6 | 2015 | 577 | 0.480 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 617 | 0.470 |
Why?
|
Protein Binding | 14 | 2022 | 3528 | 0.470 |
Why?
|
Chromosomal Instability | 2 | 2006 | 230 | 0.470 |
Why?
|
RNA, Messenger | 16 | 2010 | 6489 | 0.450 |
Why?
|
Mice, Mutant Strains | 7 | 2014 | 664 | 0.450 |
Why?
|
Neoplasm Metastasis | 8 | 2021 | 5330 | 0.450 |
Why?
|
Radiation Injuries | 2 | 2019 | 1472 | 0.440 |
Why?
|
Ribosomal Proteins | 2 | 2011 | 135 | 0.440 |
Why?
|
Intestinal Mucosa | 3 | 2009 | 1125 | 0.440 |
Why?
|
Tumor Protein p73 | 5 | 2015 | 114 | 0.430 |
Why?
|
Gene Deletion | 8 | 2014 | 1487 | 0.430 |
Why?
|
Gene Expression | 8 | 2017 | 3690 | 0.430 |
Why?
|
Base Sequence | 30 | 2008 | 5502 | 0.430 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2174 | 0.430 |
Why?
|
Reactive Oxygen Species | 4 | 2022 | 1011 | 0.430 |
Why?
|
Co-Repressor Proteins | 4 | 2023 | 120 | 0.430 |
Why?
|
Genes, ras | 4 | 2014 | 681 | 0.420 |
Why?
|
Cell Proliferation | 14 | 2024 | 7302 | 0.420 |
Why?
|
Breast Neoplasms | 10 | 2022 | 16244 | 0.420 |
Why?
|
Genes | 8 | 2001 | 613 | 0.410 |
Why?
|
Neoplasm Proteins | 9 | 2006 | 3363 | 0.410 |
Why?
|
Lymphoma, B-Cell | 3 | 2015 | 936 | 0.410 |
Why?
|
Female | 65 | 2024 | 149288 | 0.410 |
Why?
|
Molecular Chaperones | 4 | 2023 | 268 | 0.400 |
Why?
|
Radiation Tolerance | 5 | 2018 | 636 | 0.400 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2017 | 5603 | 0.390 |
Why?
|
Trans-Activators | 8 | 2015 | 1660 | 0.390 |
Why?
|
Zebrafish Proteins | 1 | 2012 | 158 | 0.390 |
Why?
|
X-linked Nuclear Protein | 3 | 2022 | 55 | 0.380 |
Why?
|
Histone Chaperones | 2 | 2023 | 32 | 0.380 |
Why?
|
Hemangiosarcoma | 1 | 2014 | 238 | 0.380 |
Why?
|
Heterozygote | 6 | 2016 | 1057 | 0.380 |
Why?
|
Cyclins | 8 | 2002 | 470 | 0.380 |
Why?
|
Crosses, Genetic | 7 | 2013 | 257 | 0.360 |
Why?
|
DNA | 17 | 2023 | 3089 | 0.360 |
Why?
|
Oncogenes | 5 | 2011 | 701 | 0.360 |
Why?
|
Cells, Cultured | 18 | 2021 | 5788 | 0.350 |
Why?
|
Adenocarcinoma | 3 | 2024 | 7976 | 0.350 |
Why?
|
Inflammation | 1 | 2020 | 2535 | 0.350 |
Why?
|
Gene Expression Regulation, Developmental | 7 | 2011 | 1524 | 0.350 |
Why?
|
Cell Death | 3 | 2023 | 689 | 0.340 |
Why?
|
Up-Regulation | 7 | 2017 | 2457 | 0.340 |
Why?
|
Limb Buds | 1 | 2009 | 30 | 0.340 |
Why?
|
Interleukin-17 | 2 | 2024 | 257 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2015 | 1547 | 0.340 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 621 | 0.340 |
Why?
|
Genes, Retinoblastoma | 1 | 2009 | 93 | 0.340 |
Why?
|
Protein Stability | 4 | 2020 | 376 | 0.330 |
Why?
|
Loss of Heterozygosity | 5 | 2017 | 626 | 0.330 |
Why?
|
Serine | 5 | 2004 | 394 | 0.320 |
Why?
|
Exonucleases | 2 | 2006 | 52 | 0.320 |
Why?
|
Molecular Sequence Data | 24 | 2007 | 6783 | 0.320 |
Why?
|
Disease Progression | 8 | 2022 | 6911 | 0.320 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 12 | 2012 | 3651 | 0.320 |
Why?
|
Myocardium | 1 | 2014 | 1252 | 0.310 |
Why?
|
Male | 53 | 2024 | 129089 | 0.310 |
Why?
|
Cell Differentiation | 12 | 2021 | 4195 | 0.310 |
Why?
|
Sarcoma | 3 | 2017 | 1842 | 0.310 |
Why?
|
Introns | 8 | 2011 | 461 | 0.310 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2018 | 4640 | 0.310 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2015 | 802 | 0.310 |
Why?
|
Genes, p16 | 1 | 2008 | 132 | 0.300 |
Why?
|
Hematopoiesis | 4 | 2016 | 608 | 0.300 |
Why?
|
Limb Deformities, Congenital | 1 | 2008 | 116 | 0.300 |
Why?
|
Genetic Engineering | 1 | 2009 | 298 | 0.300 |
Why?
|
Tumor Suppressor Protein p14ARF | 4 | 2006 | 101 | 0.290 |
Why?
|
Haploidy | 1 | 2007 | 43 | 0.290 |
Why?
|
Central Nervous System | 2 | 2009 | 457 | 0.290 |
Why?
|
DNA Primers | 9 | 2013 | 1513 | 0.290 |
Why?
|
Rhabdomyosarcoma | 1 | 2010 | 343 | 0.290 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 5 | 2011 | 507 | 0.280 |
Why?
|
Cellular Senescence | 4 | 2017 | 392 | 0.280 |
Why?
|
Repressor Proteins | 2 | 2012 | 1730 | 0.280 |
Why?
|
Receptors, Cytokine | 2 | 2018 | 183 | 0.270 |
Why?
|
Collagen | 9 | 1992 | 739 | 0.260 |
Why?
|
Sex Factors | 6 | 2019 | 2208 | 0.260 |
Why?
|
Liver | 4 | 2014 | 3124 | 0.260 |
Why?
|
Skin Neoplasms | 5 | 2017 | 4890 | 0.260 |
Why?
|
Alternative Splicing | 2 | 2006 | 613 | 0.260 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2007 | 226 | 0.260 |
Why?
|
ras Proteins | 5 | 2019 | 802 | 0.250 |
Why?
|
Mutant Proteins | 3 | 2011 | 235 | 0.250 |
Why?
|
Mitochondria | 1 | 2012 | 1314 | 0.250 |
Why?
|
Kidney | 1 | 2014 | 2267 | 0.250 |
Why?
|
Genes, Tumor Suppressor | 7 | 2011 | 1132 | 0.250 |
Why?
|
Autophagy-Related Protein-1 Homolog | 1 | 2024 | 12 | 0.240 |
Why?
|
Protein Isoforms | 3 | 2013 | 860 | 0.240 |
Why?
|
V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2024 | 33 | 0.240 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 26 | 0.240 |
Why?
|
Intestine, Small | 2 | 2020 | 527 | 0.240 |
Why?
|
Cell Division | 8 | 2017 | 2711 | 0.240 |
Why?
|
Retinoblastoma Protein | 2 | 2005 | 342 | 0.230 |
Why?
|
Cloning, Molecular | 10 | 1998 | 1458 | 0.230 |
Why?
|
Down-Regulation | 7 | 2021 | 2106 | 0.230 |
Why?
|
Stem Cells | 3 | 2007 | 1236 | 0.230 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3026 | 0.230 |
Why?
|
Homozygote | 3 | 2018 | 771 | 0.230 |
Why?
|
Phosphorylation | 12 | 2019 | 4984 | 0.230 |
Why?
|
Genotype | 8 | 2016 | 4267 | 0.230 |
Why?
|
HeLa Cells | 9 | 2013 | 1718 | 0.230 |
Why?
|
Recombinant Fusion Proteins | 9 | 2006 | 1668 | 0.230 |
Why?
|
Mice, Inbred BALB C | 6 | 2017 | 2470 | 0.220 |
Why?
|
Longevity | 2 | 2016 | 155 | 0.220 |
Why?
|
Phosphoproteins | 4 | 2013 | 1230 | 0.220 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 24 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 1 | 2010 | 918 | 0.220 |
Why?
|
TATA-Binding Protein Associated Factors | 2 | 2002 | 27 | 0.220 |
Why?
|
Mammary Glands, Animal | 3 | 2021 | 635 | 0.220 |
Why?
|
Transfection | 12 | 2015 | 3166 | 0.220 |
Why?
|
Feedback, Physiological | 2 | 2014 | 194 | 0.220 |
Why?
|
Neoplasm Invasiveness | 4 | 2019 | 4071 | 0.210 |
Why?
|
Mice, Inbred Strains | 4 | 2018 | 570 | 0.210 |
Why?
|
Blotting, Western | 7 | 2012 | 3646 | 0.210 |
Why?
|
Doxorubicin | 5 | 2014 | 3132 | 0.210 |
Why?
|
Lung Neoplasms | 9 | 2024 | 12012 | 0.210 |
Why?
|
Models, Biological | 9 | 2019 | 3223 | 0.210 |
Why?
|
Point Mutation | 4 | 2014 | 793 | 0.210 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2017 | 446 | 0.200 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 499 | 0.200 |
Why?
|
Skin | 3 | 2017 | 1284 | 0.200 |
Why?
|
Protein Structure, Tertiary | 4 | 2007 | 1501 | 0.200 |
Why?
|
Models, Animal | 3 | 2014 | 675 | 0.200 |
Why?
|
Polyamines | 1 | 2021 | 80 | 0.190 |
Why?
|
Blotting, Northern | 8 | 2003 | 735 | 0.190 |
Why?
|
Amino Acid Sequence | 15 | 2007 | 4635 | 0.190 |
Why?
|
Biomarkers, Tumor | 7 | 2021 | 10750 | 0.190 |
Why?
|
Hepatocytes | 2 | 2022 | 351 | 0.190 |
Why?
|
Transgenes | 2 | 2017 | 589 | 0.190 |
Why?
|
Wnt Signaling Pathway | 2 | 2021 | 445 | 0.190 |
Why?
|
Gamma Rays | 3 | 2004 | 241 | 0.190 |
Why?
|
Islets of Langerhans | 1 | 2022 | 241 | 0.190 |
Why?
|
Pseudogenes | 1 | 2001 | 92 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2013 | 503 | 0.190 |
Why?
|
Primary Cell Culture | 2 | 2021 | 203 | 0.190 |
Why?
|
S Phase | 2 | 1999 | 290 | 0.190 |
Why?
|
Polymerization | 1 | 2020 | 18 | 0.190 |
Why?
|
Models, Theoretical | 2 | 2008 | 809 | 0.190 |
Why?
|
Pancreas | 2 | 2024 | 746 | 0.180 |
Why?
|
Duodenal Neoplasms | 1 | 2021 | 139 | 0.180 |
Why?
|
Penetrance | 1 | 2021 | 134 | 0.180 |
Why?
|
Immunohistochemistry | 6 | 2016 | 7828 | 0.180 |
Why?
|
DNA Repair | 3 | 2010 | 1912 | 0.180 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2021 | 143 | 0.180 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2020 | 512 | 0.180 |
Why?
|
Osteoblasts | 3 | 2021 | 394 | 0.180 |
Why?
|
beta Catenin | 2 | 2021 | 691 | 0.180 |
Why?
|
MAP Kinase Signaling System | 2 | 2019 | 889 | 0.180 |
Why?
|
Carcinosarcoma | 1 | 2021 | 149 | 0.180 |
Why?
|
Ribonucleotide Reductases | 1 | 2000 | 48 | 0.180 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 14653 | 0.170 |
Why?
|
Cell Plasticity | 1 | 2020 | 67 | 0.170 |
Why?
|
DNA Mutational Analysis | 9 | 2017 | 2365 | 0.170 |
Why?
|
Sequence Deletion | 5 | 2016 | 915 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2020 | 177 | 0.170 |
Why?
|
Heart | 1 | 2006 | 1214 | 0.170 |
Why?
|
Transforming Growth Factor beta | 3 | 2013 | 1133 | 0.160 |
Why?
|
Mutagenesis, Site-Directed | 5 | 2004 | 641 | 0.160 |
Why?
|
Radiation Injuries, Experimental | 1 | 2019 | 82 | 0.160 |
Why?
|
Neoplastic Stem Cells | 3 | 2018 | 1469 | 0.160 |
Why?
|
Genes, myc | 2 | 2011 | 375 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2085 | 0.160 |
Why?
|
3T3 Cells | 7 | 2011 | 387 | 0.160 |
Why?
|
Protein Domains | 1 | 2020 | 324 | 0.160 |
Why?
|
Histones | 5 | 2018 | 1514 | 0.160 |
Why?
|
Mutation Rate | 1 | 2019 | 220 | 0.160 |
Why?
|
Rats | 8 | 2018 | 6640 | 0.160 |
Why?
|
Peptide Hydrolases | 2 | 2011 | 264 | 0.160 |
Why?
|
Germ Cells | 1 | 2021 | 351 | 0.160 |
Why?
|
Gene Knock-In Techniques | 5 | 2021 | 184 | 0.160 |
Why?
|
Chromosomes, Human, X | 1 | 2019 | 201 | 0.160 |
Why?
|
Hyperpigmentation | 2 | 2016 | 35 | 0.160 |
Why?
|
Fungal Proteins | 3 | 1998 | 272 | 0.160 |
Why?
|
Spondylarthropathies | 1 | 2018 | 5 | 0.160 |
Why?
|
Recombinational DNA Repair | 1 | 2018 | 78 | 0.150 |
Why?
|
Protein Transport | 1 | 2020 | 739 | 0.150 |
Why?
|
Cell Survival | 8 | 2015 | 3074 | 0.150 |
Why?
|
Adenocarcinoma in Situ | 1 | 2018 | 31 | 0.150 |
Why?
|
Keratinocytes | 2 | 2017 | 247 | 0.150 |
Why?
|
DNA End-Joining Repair | 1 | 2018 | 92 | 0.150 |
Why?
|
Phosphoserine | 2 | 2001 | 109 | 0.150 |
Why?
|
Chromosome Mapping | 5 | 2006 | 1650 | 0.150 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2018 | 1615 | 0.150 |
Why?
|
Biomarkers | 3 | 2020 | 5115 | 0.150 |
Why?
|
Cell Line | 9 | 2013 | 5433 | 0.150 |
Why?
|
fas Receptor | 2 | 2002 | 197 | 0.150 |
Why?
|
Thymus Gland | 2 | 2004 | 312 | 0.150 |
Why?
|
Leupeptins | 2 | 2014 | 73 | 0.150 |
Why?
|
Melanocytes | 2 | 2016 | 241 | 0.140 |
Why?
|
Laryngeal Neoplasms | 1 | 2001 | 533 | 0.140 |
Why?
|
RNA Splicing | 2 | 2017 | 362 | 0.140 |
Why?
|
Obesity | 2 | 2023 | 2958 | 0.140 |
Why?
|
Receptors, Endothelin | 2 | 2014 | 25 | 0.140 |
Why?
|
Mice, Nude | 5 | 2021 | 4360 | 0.140 |
Why?
|
Receptors, Angiotensin | 2 | 2014 | 46 | 0.140 |
Why?
|
Receptors, Interleukin | 4 | 2018 | 99 | 0.140 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 681 | 0.140 |
Why?
|
NF-kappa B | 2 | 2013 | 1569 | 0.140 |
Why?
|
History, 21st Century | 1 | 2018 | 422 | 0.140 |
Why?
|
RNA, Neoplasm | 2 | 2014 | 810 | 0.140 |
Why?
|
Transformation, Genetic | 3 | 2001 | 70 | 0.140 |
Why?
|
Epithelial Cells | 4 | 2024 | 1892 | 0.140 |
Why?
|
Bromodeoxyuridine | 3 | 2009 | 138 | 0.140 |
Why?
|
Mitosis | 4 | 2007 | 692 | 0.140 |
Why?
|
Genetic Vectors | 3 | 2003 | 1887 | 0.140 |
Why?
|
Interleukin-27 | 1 | 2016 | 7 | 0.140 |
Why?
|
Oxidative Phosphorylation | 1 | 2018 | 267 | 0.130 |
Why?
|
Oncogene Proteins | 2 | 2005 | 370 | 0.130 |
Why?
|
Receptor, Endothelin A | 1 | 2016 | 18 | 0.130 |
Why?
|
History, 20th Century | 1 | 2018 | 550 | 0.130 |
Why?
|
Carcinogens | 1 | 2017 | 398 | 0.130 |
Why?
|
Cell Growth Processes | 2 | 2014 | 340 | 0.130 |
Why?
|
Contact Inhibition | 1 | 1995 | 10 | 0.130 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 1575 | 0.130 |
Why?
|
Mouth Neoplasms | 1 | 2001 | 734 | 0.130 |
Why?
|
Clonal Evolution | 1 | 2017 | 251 | 0.130 |
Why?
|
NFI Transcription Factors | 1 | 2015 | 78 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 2357 | 0.130 |
Why?
|
Animals, Genetically Modified | 2 | 2015 | 417 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2013 | 355 | 0.120 |
Why?
|
Polycomb Repressive Complex 2 | 1 | 2015 | 160 | 0.120 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2007 | 1093 | 0.120 |
Why?
|
Mitochondrial Turnover | 1 | 2014 | 6 | 0.120 |
Why?
|
Polymerase Chain Reaction | 8 | 2014 | 3512 | 0.120 |
Why?
|
RNA, Small Interfering | 5 | 2022 | 2219 | 0.120 |
Why?
|
Drug Synergism | 1 | 2018 | 1364 | 0.120 |
Why?
|
Immunomodulation | 1 | 2016 | 255 | 0.120 |
Why?
|
Cycloheximide | 1 | 2014 | 111 | 0.120 |
Why?
|
Heart Defects, Congenital | 1 | 2006 | 1782 | 0.120 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 2 | 2006 | 437 | 0.120 |
Why?
|
Tumor Cells, Cultured | 15 | 2003 | 5804 | 0.110 |
Why?
|
Dactinomycin | 1 | 2014 | 163 | 0.110 |
Why?
|
Response Elements | 1 | 2014 | 201 | 0.110 |
Why?
|
Ubiquitin-Specific Proteases | 1 | 2014 | 71 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2014 | 98 | 0.110 |
Why?
|
Pedigree | 7 | 2011 | 2036 | 0.110 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2014 | 171 | 0.110 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2014 | 191 | 0.110 |
Why?
|
Ploidies | 2 | 2004 | 257 | 0.110 |
Why?
|
Injections | 1 | 2014 | 287 | 0.110 |
Why?
|
B-Lymphocytes | 2 | 2010 | 1429 | 0.110 |
Why?
|
Cerebellum | 2 | 2007 | 477 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 2496 | 0.110 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 227 | 0.110 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2015 | 294 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 5421 | 0.110 |
Why?
|
Chromosome Inversion | 1 | 2014 | 197 | 0.110 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2013 | 441 | 0.110 |
Why?
|
Binding Sites | 6 | 2012 | 2298 | 0.110 |
Why?
|
G1 Phase Cell Cycle Checkpoints | 1 | 2013 | 46 | 0.110 |
Why?
|
Transcription Factor RelA | 1 | 2013 | 186 | 0.110 |
Why?
|
Psoriasis | 1 | 2014 | 138 | 0.110 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1288 | 0.110 |
Why?
|
Animals, Newborn | 3 | 2007 | 1396 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2017 | 5187 | 0.110 |
Why?
|
Chickens | 4 | 2010 | 791 | 0.110 |
Why?
|
Th1 Cells | 1 | 2014 | 260 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 2 | 1995 | 504 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 848 | 0.100 |
Why?
|
Head and Neck Neoplasms | 2 | 2007 | 4138 | 0.100 |
Why?
|
Cell Cycle Checkpoints | 1 | 2014 | 272 | 0.100 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 1993 | 473 | 0.100 |
Why?
|
Fatty Liver | 1 | 2014 | 257 | 0.100 |
Why?
|
beta-Galactosidase | 2 | 2009 | 278 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6270 | 0.100 |
Why?
|
Prostatic Neoplasms | 4 | 2022 | 5996 | 0.100 |
Why?
|
Genomic Instability | 1 | 2015 | 523 | 0.100 |
Why?
|
Proteolysis | 1 | 2014 | 380 | 0.100 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2011 | 28 | 0.100 |
Why?
|
Survival Analysis | 4 | 2010 | 9326 | 0.100 |
Why?
|
Precipitin Tests | 4 | 2003 | 360 | 0.100 |
Why?
|
Genomics | 3 | 2017 | 2830 | 0.100 |
Why?
|
Glioblastoma | 1 | 2022 | 1781 | 0.100 |
Why?
|
Research Report | 1 | 2012 | 144 | 0.100 |
Why?
|
Smad Proteins | 1 | 2011 | 82 | 0.100 |
Why?
|
Blotting, Southern | 2 | 2011 | 455 | 0.100 |
Why?
|
Glioma | 1 | 2022 | 1988 | 0.100 |
Why?
|
Transcription Factor TFIID | 2 | 2002 | 26 | 0.090 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 196 | 0.090 |
Why?
|
Myocytes, Cardiac | 2 | 2007 | 710 | 0.090 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2011 | 72 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2012 | 255 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2014 | 1004 | 0.090 |
Why?
|
DNA-Activated Protein Kinase | 2 | 2022 | 76 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2013 | 569 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 3 | 2007 | 703 | 0.090 |
Why?
|
Flow Cytometry | 3 | 2018 | 3078 | 0.090 |
Why?
|
Exons | 5 | 2003 | 1388 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 265 | 0.090 |
Why?
|
Cerebellar Ataxia | 1 | 2011 | 73 | 0.090 |
Why?
|
Casein Kinase II | 3 | 2001 | 60 | 0.090 |
Why?
|
Lipids | 1 | 2014 | 662 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2014 | 494 | 0.090 |
Why?
|
Zinc Fingers | 2 | 2005 | 224 | 0.090 |
Why?
|
Cell Movement | 4 | 2016 | 2504 | 0.090 |
Why?
|
Immunoprecipitation | 2 | 2013 | 593 | 0.090 |
Why?
|
Polymorphism, Single-Stranded Conformational | 3 | 1999 | 192 | 0.090 |
Why?
|
Oligonucleotides | 2 | 2010 | 245 | 0.090 |
Why?
|
Retina | 1 | 2014 | 543 | 0.090 |
Why?
|
ErbB Receptors | 3 | 2022 | 2383 | 0.090 |
Why?
|
Protein Multimerization | 1 | 2011 | 233 | 0.090 |
Why?
|
5' Untranslated Regions | 1 | 2010 | 99 | 0.090 |
Why?
|
bcl-2-Associated X Protein | 2 | 2003 | 380 | 0.090 |
Why?
|
Survival Rate | 4 | 2007 | 12534 | 0.090 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 1146 | 0.090 |
Why?
|
Genes, Dominant | 3 | 2011 | 360 | 0.090 |
Why?
|
Chemokine CXCL12 | 1 | 2010 | 136 | 0.090 |
Why?
|
Proto-Oncogenes | 1 | 1990 | 208 | 0.090 |
Why?
|
Osteogenesis | 3 | 2021 | 271 | 0.090 |
Why?
|
Feedback | 2 | 2010 | 228 | 0.090 |
Why?
|
Adipocytes | 1 | 2012 | 308 | 0.090 |
Why?
|
E2F3 Transcription Factor | 1 | 2009 | 23 | 0.090 |
Why?
|
Nevus | 1 | 2010 | 117 | 0.090 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2011 | 131 | 0.090 |
Why?
|
Retinoblastoma | 1 | 2011 | 189 | 0.090 |
Why?
|
Chromosome Aberrations | 1 | 2017 | 2035 | 0.090 |
Why?
|
DNA Replication | 2 | 2004 | 773 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2011 | 490 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 339 | 0.080 |
Why?
|
Cisplatin | 3 | 2016 | 2497 | 0.080 |
Why?
|
CD3 Complex | 1 | 2010 | 321 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2024 | 5566 | 0.080 |
Why?
|
Macrophages | 1 | 2016 | 1378 | 0.080 |
Why?
|
Genome, Human | 2 | 2015 | 1885 | 0.080 |
Why?
|
Tumor Burden | 2 | 2012 | 2035 | 0.080 |
Why?
|
Cell Nucleus | 5 | 2004 | 1740 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 2 | 2022 | 1014 | 0.080 |
Why?
|
Bone Marrow | 2 | 2007 | 2446 | 0.080 |
Why?
|
Exoribonucleases | 2 | 2006 | 43 | 0.080 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2008 | 50 | 0.080 |
Why?
|
Time Factors | 9 | 2017 | 13139 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 389 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2014 | 748 | 0.080 |
Why?
|
RNA-Binding Protein EWS | 1 | 2008 | 106 | 0.080 |
Why?
|
Enzyme Activation | 4 | 2007 | 1832 | 0.080 |
Why?
|
Mice, 129 Strain | 2 | 2021 | 163 | 0.080 |
Why?
|
Breast | 3 | 2021 | 1380 | 0.080 |
Why?
|
Restriction Mapping | 4 | 1998 | 336 | 0.080 |
Why?
|
Hippocampus | 1 | 2014 | 978 | 0.080 |
Why?
|
14-3-3 Proteins | 2 | 2006 | 143 | 0.080 |
Why?
|
Pregnancy | 4 | 2023 | 8105 | 0.070 |
Why?
|
Methylation | 3 | 2015 | 626 | 0.070 |
Why?
|
Immunoblotting | 4 | 2013 | 909 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2010 | 431 | 0.070 |
Why?
|
Models, Genetic | 2 | 2014 | 1169 | 0.070 |
Why?
|
G1 Phase | 2 | 2000 | 306 | 0.070 |
Why?
|
Actins | 1 | 2010 | 617 | 0.070 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2007 | 107 | 0.070 |
Why?
|
Growth | 1 | 2007 | 125 | 0.070 |
Why?
|
Tripartite Motif Proteins | 3 | 2014 | 51 | 0.070 |
Why?
|
Disease-Free Survival | 2 | 2017 | 10259 | 0.070 |
Why?
|
Polymorphism, Genetic | 3 | 2014 | 1559 | 0.070 |
Why?
|
Protein Biosynthesis | 2 | 2010 | 1035 | 0.070 |
Why?
|
Papilloma | 4 | 2007 | 88 | 0.070 |
Why?
|
Erythropoiesis | 1 | 2006 | 79 | 0.070 |
Why?
|
Ubiquitin-Specific Peptidase 7 | 1 | 2006 | 40 | 0.070 |
Why?
|
X-Ray Microtomography | 2 | 2018 | 138 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2008 | 392 | 0.070 |
Why?
|
Caffeine | 1 | 2006 | 96 | 0.070 |
Why?
|
Tripartite Motif-Containing Protein 28 | 1 | 2006 | 38 | 0.070 |
Why?
|
DNA Modification Methylases | 1 | 2006 | 176 | 0.070 |
Why?
|
Centromere | 2 | 2023 | 139 | 0.060 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 716 | 0.060 |
Why?
|
Medical Informatics | 1 | 2008 | 195 | 0.060 |
Why?
|
Adipogenesis | 2 | 2021 | 104 | 0.060 |
Why?
|
Erythrocytes | 1 | 2006 | 340 | 0.060 |
Why?
|
Protein Kinases | 1 | 2009 | 919 | 0.060 |
Why?
|
Spermatogenesis | 1 | 2007 | 334 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 2333 | 0.060 |
Why?
|
Hepatomegaly | 1 | 2005 | 72 | 0.060 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2634 | 0.060 |
Why?
|
DNA Repair Enzymes | 1 | 2006 | 236 | 0.060 |
Why?
|
RNA Interference | 3 | 2015 | 1397 | 0.060 |
Why?
|
Biomedical Research | 1 | 2012 | 802 | 0.060 |
Why?
|
Temperature | 2 | 2000 | 540 | 0.060 |
Why?
|
Histone Acetyltransferases | 1 | 2007 | 442 | 0.060 |
Why?
|
Pyridines | 2 | 2024 | 1312 | 0.060 |
Why?
|
Mosaicism | 1 | 2007 | 293 | 0.060 |
Why?
|
Endopeptidases | 1 | 2006 | 233 | 0.060 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 1995 | 139 | 0.060 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2006 | 224 | 0.060 |
Why?
|
Gene Silencing | 1 | 2007 | 834 | 0.060 |
Why?
|
Simian virus 40 | 4 | 1991 | 248 | 0.060 |
Why?
|
Ankyrins | 1 | 2005 | 110 | 0.060 |
Why?
|
Drosophila | 2 | 2007 | 911 | 0.060 |
Why?
|
Lod Score | 1 | 2004 | 169 | 0.060 |
Why?
|
Teratoma | 2 | 1999 | 253 | 0.060 |
Why?
|
HCT116 Cells | 2 | 2015 | 354 | 0.060 |
Why?
|
Mathematics | 1 | 2004 | 141 | 0.060 |
Why?
|
High Mobility Group Proteins | 2 | 2001 | 65 | 0.060 |
Why?
|
Fetal Death | 1 | 2004 | 134 | 0.060 |
Why?
|
Genetic Markers | 2 | 2004 | 1077 | 0.060 |
Why?
|
E2F1 Transcription Factor | 2 | 2009 | 201 | 0.060 |
Why?
|
Adenovirus E1A Proteins | 1 | 2004 | 165 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2010 | 1136 | 0.060 |
Why?
|
Haplotypes | 2 | 2014 | 909 | 0.060 |
Why?
|
Proteins | 3 | 2000 | 2058 | 0.060 |
Why?
|
cdc25 Phosphatases | 1 | 2004 | 101 | 0.060 |
Why?
|
Nucleotides | 2 | 2004 | 175 | 0.060 |
Why?
|
Multigene Family | 1 | 2005 | 465 | 0.060 |
Why?
|
Genes, Recessive | 1 | 2004 | 202 | 0.060 |
Why?
|
Telomere | 1 | 2007 | 547 | 0.060 |
Why?
|
Amino Acid Substitution | 3 | 2018 | 661 | 0.060 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4797 | 0.060 |
Why?
|
Middle Aged | 9 | 2021 | 90460 | 0.060 |
Why?
|
Choroid Plexus | 3 | 1988 | 37 | 0.050 |
Why?
|
Neural Tube Defects | 1 | 2007 | 369 | 0.050 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1994 | 294 | 0.050 |
Why?
|
Ligases | 1 | 2003 | 85 | 0.050 |
Why?
|
Lactation | 2 | 2002 | 244 | 0.050 |
Why?
|
Teratocarcinoma | 2 | 1999 | 24 | 0.050 |
Why?
|
MCF-7 Cells | 2 | 2015 | 554 | 0.050 |
Why?
|
alpha-Thalassemia | 1 | 2022 | 11 | 0.050 |
Why?
|
Whole-Body Irradiation | 2 | 2009 | 324 | 0.050 |
Why?
|
Ubiquitins | 1 | 2003 | 100 | 0.050 |
Why?
|
Methoxsalen | 1 | 2002 | 7 | 0.050 |
Why?
|
Embryonic and Fetal Development | 2 | 1998 | 229 | 0.050 |
Why?
|
Cerebral Ventricle Neoplasms | 3 | 1988 | 78 | 0.050 |
Why?
|
Neuroblastoma | 2 | 2005 | 703 | 0.050 |
Why?
|
Pleural Neoplasms | 1 | 2007 | 487 | 0.050 |
Why?
|
Cytoplasm | 2 | 2002 | 719 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2001 | 883 | 0.050 |
Why?
|
Adult | 13 | 2021 | 81933 | 0.050 |
Why?
|
Aged | 7 | 2021 | 73517 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2001 | 422 | 0.050 |
Why?
|
Smad3 Protein | 2 | 2013 | 125 | 0.050 |
Why?
|
Plasmids | 5 | 2002 | 953 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2018 | 1470 | 0.050 |
Why?
|
Giant Cells | 1 | 2002 | 73 | 0.050 |
Why?
|
Mesothelioma | 1 | 2007 | 560 | 0.050 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 506 | 0.050 |
Why?
|
Cohort Studies | 4 | 2017 | 9500 | 0.050 |
Why?
|
Muridae | 1 | 2001 | 23 | 0.050 |
Why?
|
Epidermis | 1 | 2002 | 200 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 3 | 2012 | 745 | 0.050 |
Why?
|
Mental Retardation, X-Linked | 1 | 2022 | 100 | 0.050 |
Why?
|
Son of Sevenless Proteins | 1 | 2001 | 8 | 0.050 |
Why?
|
Genetic Linkage | 2 | 2005 | 601 | 0.050 |
Why?
|
Chondrogenesis | 1 | 2021 | 64 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 1483 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2021 | 6236 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 7258 | 0.050 |
Why?
|
Transcriptional Elongation Factors | 1 | 2001 | 42 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 1 | 2001 | 449 | 0.050 |
Why?
|
Haploinsufficiency | 2 | 2013 | 303 | 0.050 |
Why?
|
Acetamides | 1 | 2001 | 113 | 0.050 |
Why?
|
DNA, Neoplasm | 1 | 2006 | 1972 | 0.050 |
Why?
|
COP9 Signalosome Complex | 2 | 2011 | 80 | 0.050 |
Why?
|
Brazil | 1 | 2021 | 172 | 0.050 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2003 | 252 | 0.050 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 642 | 0.050 |
Why?
|
Genes, Synthetic | 1 | 2000 | 30 | 0.040 |
Why?
|
Integrases | 1 | 2002 | 266 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2003 | 668 | 0.040 |
Why?
|
Genomic Library | 2 | 1998 | 58 | 0.040 |
Why?
|
Piperazines | 2 | 2024 | 2152 | 0.040 |
Why?
|
Terminal Repeat Sequences | 1 | 1999 | 29 | 0.040 |
Why?
|
Thyroid Neoplasms | 1 | 2011 | 1884 | 0.040 |
Why?
|
Spermatocytes | 1 | 1999 | 48 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2015 | 1966 | 0.040 |
Why?
|
Risk Factors | 3 | 2014 | 18051 | 0.040 |
Why?
|
Genes, X-Linked | 1 | 2019 | 67 | 0.040 |
Why?
|
Growth Disorders | 2 | 2011 | 224 | 0.040 |
Why?
|
DNA Helicases | 1 | 2022 | 451 | 0.040 |
Why?
|
Cartilage | 3 | 1991 | 112 | 0.040 |
Why?
|
Imidazoles | 2 | 2010 | 1056 | 0.040 |
Why?
|
Gene Library | 1 | 2001 | 355 | 0.040 |
Why?
|
Codon | 3 | 2010 | 262 | 0.040 |
Why?
|
Cell Lineage | 2 | 2015 | 706 | 0.040 |
Why?
|
Transcription Factors, TFII | 1 | 1999 | 23 | 0.040 |
Why?
|
Tissue Distribution | 2 | 1999 | 947 | 0.040 |
Why?
|
Retinoblastoma-Binding Protein 1 | 1 | 1999 | 57 | 0.040 |
Why?
|
Transcription Factor DP1 | 1 | 1999 | 59 | 0.040 |
Why?
|
Whole Genome Sequencing | 1 | 2021 | 367 | 0.040 |
Why?
|
Pyridazines | 1 | 2022 | 319 | 0.040 |
Why?
|
Cyclin A | 1 | 1999 | 50 | 0.040 |
Why?
|
United States | 4 | 2021 | 16066 | 0.040 |
Why?
|
Viral Proteins | 1 | 2002 | 493 | 0.040 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 2 | 2010 | 129 | 0.040 |
Why?
|
E2F Transcription Factors | 1 | 1999 | 138 | 0.040 |
Why?
|
Protein Interaction Maps | 1 | 2019 | 150 | 0.040 |
Why?
|
Prognosis | 5 | 2021 | 22555 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 1999 | 156 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 223 | 0.040 |
Why?
|
Thyroid Gland | 2 | 2011 | 369 | 0.040 |
Why?
|
Aspergillus nidulans | 1 | 1998 | 29 | 0.040 |
Why?
|
Neurons | 2 | 2007 | 2462 | 0.040 |
Why?
|
Octamer Transcription Factors | 1 | 2018 | 18 | 0.040 |
Why?
|
Testicular Neoplasms | 2 | 1999 | 555 | 0.040 |
Why?
|
Genes, Fungal | 1 | 1998 | 97 | 0.040 |
Why?
|
Gene Amplification | 1 | 2001 | 770 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 428 | 0.040 |
Why?
|
Autophagy | 1 | 2024 | 922 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2001 | 689 | 0.040 |
Why?
|
Retinal Dehydrogenase | 1 | 2018 | 88 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 1997 | 26 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1999 | 274 | 0.040 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2018 | 107 | 0.040 |
Why?
|
Blastomeres | 1 | 1997 | 24 | 0.040 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2018 | 143 | 0.040 |
Why?
|
Quinazolines | 1 | 2022 | 953 | 0.040 |
Why?
|
Antibody Specificity | 1 | 1998 | 340 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 3704 | 0.040 |
Why?
|
Autoantigens | 1 | 1998 | 250 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 1105 | 0.040 |
Why?
|
Pancreatitis, Chronic | 1 | 2018 | 127 | 0.040 |
Why?
|
Sp1 Transcription Factor | 2 | 2010 | 193 | 0.040 |
Why?
|
Promyelocytic Leukemia Protein | 2 | 2013 | 56 | 0.040 |
Why?
|
Prostate | 1 | 2022 | 1138 | 0.040 |
Why?
|
Transforming Growth Factor alpha | 1 | 1997 | 95 | 0.030 |
Why?
|
Cyclin E | 1 | 1999 | 283 | 0.030 |
Why?
|
Creatine Kinase | 2 | 1995 | 97 | 0.030 |
Why?
|
Caenorhabditis elegans | 1 | 2018 | 282 | 0.030 |
Why?
|
Antisense Elements (Genetics) | 1 | 1996 | 21 | 0.030 |
Why?
|
Cosmids | 1 | 1996 | 58 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 682 | 0.030 |
Why?
|
Luciferases | 2 | 2010 | 464 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 1998 | 381 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2001 | 2576 | 0.030 |
Why?
|
Indoles | 1 | 2001 | 1034 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2015 | 103 | 0.030 |
Why?
|
Gene Order | 1 | 2015 | 109 | 0.030 |
Why?
|
Aflatoxin B1 | 1 | 1995 | 8 | 0.030 |
Why?
|
Jejunum | 1 | 1997 | 234 | 0.030 |
Why?
|
Gene Frequency | 3 | 2004 | 1241 | 0.030 |
Why?
|
SEER Program | 1 | 2019 | 1047 | 0.030 |
Why?
|
Antigens, Polyomavirus Transforming | 2 | 1993 | 154 | 0.030 |
Why?
|
Polycomb Repressive Complex 1 | 1 | 2015 | 87 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2021 | 15279 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2015 | 112 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 1994 | 1005 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 1997 | 445 | 0.030 |
Why?
|
Phylogeny | 1 | 2017 | 870 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 1998 | 281 | 0.030 |
Why?
|
Suppression, Genetic | 2 | 1994 | 71 | 0.030 |
Why?
|
Acids | 1 | 1994 | 39 | 0.030 |
Why?
|
RNA | 2 | 2005 | 1072 | 0.030 |
Why?
|
Glutamic Acid | 1 | 1996 | 335 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2015 | 297 | 0.030 |
Why?
|
Ganglia, Spinal | 1 | 1996 | 255 | 0.030 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2015 | 330 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1997 | 668 | 0.030 |
Why?
|
Cell Count | 1 | 1995 | 524 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2014 | 1313 | 0.030 |
Why?
|
Listeriosis | 1 | 2014 | 43 | 0.030 |
Why?
|
Exome | 1 | 2019 | 1252 | 0.030 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 73 | 0.030 |
Why?
|
Listeria monocytogenes | 1 | 2014 | 61 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 514 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 1995 | 256 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1061 | 0.030 |
Why?
|
Smoking | 1 | 2003 | 2538 | 0.030 |
Why?
|
Genetic Testing | 2 | 2004 | 1699 | 0.030 |
Why?
|
Protein Denaturation | 1 | 2013 | 72 | 0.030 |
Why?
|
Protein Kinase C | 1 | 1995 | 419 | 0.030 |
Why?
|
Genes, Reporter | 3 | 2003 | 832 | 0.030 |
Why?
|
Heterografts | 1 | 2016 | 745 | 0.030 |
Why?
|
Azoxymethane | 1 | 2013 | 43 | 0.030 |
Why?
|
Protein Conformation | 2 | 1995 | 1278 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1999 | 2319 | 0.030 |
Why?
|
Proteomics | 1 | 2021 | 1437 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2013 | 70 | 0.030 |
Why?
|
Clone Cells | 2 | 2010 | 589 | 0.030 |
Why?
|
Melanoma | 1 | 2010 | 5592 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2014 | 227 | 0.030 |
Why?
|
Snail Family Transcription Factors | 1 | 2013 | 122 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 1994 | 374 | 0.030 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 278 | 0.030 |
Why?
|
Isoenzymes | 1 | 1995 | 663 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2008 | 434 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2015 | 1074 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 2903 | 0.030 |
Why?
|
Financing, Government | 1 | 2012 | 38 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2021 | 3929 | 0.030 |
Why?
|
Societies, Scientific | 1 | 2012 | 69 | 0.030 |
Why?
|
Age Factors | 2 | 2015 | 5526 | 0.030 |
Why?
|
Cell Communication | 1 | 1995 | 518 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2013 | 398 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2014 | 254 | 0.030 |
Why?
|
Base Composition | 1 | 1992 | 93 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 267 | 0.030 |
Why?
|
Muscle Cells | 1 | 2012 | 33 | 0.030 |
Why?
|
Wnt1 Protein | 1 | 2012 | 102 | 0.030 |
Why?
|
Tumor Escape | 1 | 2014 | 248 | 0.030 |
Why?
|
Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2011 | 15 | 0.030 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 2012 | 148 | 0.030 |
Why?
|
Guanidine | 1 | 1991 | 14 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2003 | 320 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2012 | 120 | 0.020 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 1991 | 26 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2014 | 436 | 0.020 |
Why?
|
Pyrimidines | 1 | 2024 | 3664 | 0.020 |
Why?
|
Chick Embryo | 3 | 1987 | 219 | 0.020 |
Why?
|
Growth Plate | 1 | 1991 | 43 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 273 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 385 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2011 | 92 | 0.020 |
Why?
|
Guanidines | 1 | 1991 | 61 | 0.020 |
Why?
|
Cesium Radioisotopes | 1 | 2011 | 38 | 0.020 |
Why?
|
NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2011 | 63 | 0.020 |
Why?
|
Mutagenicity Tests | 1 | 2011 | 70 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 3856 | 0.020 |
Why?
|
Cell Line, Transformed | 2 | 2003 | 431 | 0.020 |
Why?
|
Pigmentation | 1 | 2010 | 52 | 0.020 |
Why?
|
Plicamycin | 1 | 2010 | 30 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 1994 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2014 | 498 | 0.020 |
Why?
|
Databases, Factual | 1 | 2018 | 2290 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 158 | 0.020 |
Why?
|
Genetic Therapy | 1 | 1998 | 1739 | 0.020 |
Why?
|
Zinostatin | 1 | 2009 | 4 | 0.020 |
Why?
|
Dromaiidae | 1 | 2009 | 4 | 0.020 |
Why?
|
Blastocyst | 1 | 2010 | 144 | 0.020 |
Why?
|
E2F5 Transcription Factor | 1 | 2009 | 8 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2010 | 159 | 0.020 |
Why?
|
E2F2 Transcription Factor | 1 | 2009 | 27 | 0.020 |
Why?
|
Rad51 Recombinase | 1 | 2010 | 125 | 0.020 |
Why?
|
Colitis | 1 | 2013 | 344 | 0.020 |
Why?
|
E2F4 Transcription Factor | 1 | 2009 | 30 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2011 | 4968 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 1212 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1995 | 3072 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 473 | 0.020 |
Why?
|
Colon | 1 | 2013 | 691 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2010 | 466 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 1728 | 0.020 |
Why?
|
Arginine | 2 | 2007 | 510 | 0.020 |
Why?
|
Checkpoint Kinase 1 | 1 | 2009 | 169 | 0.020 |
Why?
|
Learning | 1 | 2012 | 433 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 1086 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 22142 | 0.020 |
Why?
|
Genes, Viral | 1 | 1988 | 257 | 0.020 |
Why?
|
Glycosaminoglycans | 1 | 1987 | 71 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 3148 | 0.020 |
Why?
|
Etoposide | 1 | 2009 | 905 | 0.020 |
Why?
|
Antigens, Viral, Tumor | 1 | 1987 | 76 | 0.020 |
Why?
|
Incidence | 2 | 2010 | 5864 | 0.020 |
Why?
|
Embryo Loss | 1 | 2007 | 42 | 0.020 |
Why?
|
Centrosome | 1 | 2007 | 107 | 0.020 |
Why?
|
Adolescent | 4 | 2011 | 32730 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 1986 | 632 | 0.020 |
Why?
|
Receptors, Serotonin | 1 | 1986 | 59 | 0.020 |
Why?
|
Molecular Weight | 3 | 2001 | 727 | 0.020 |
Why?
|
Stromal Cells | 1 | 2010 | 835 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1987 | 148 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 1851 | 0.020 |
Why?
|
Body Weight | 1 | 2011 | 1335 | 0.020 |
Why?
|
Proteoglycans | 1 | 1987 | 278 | 0.020 |
Why?
|
p300-CBP Transcription Factors | 1 | 2007 | 111 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2006 | 5118 | 0.020 |
Why?
|
Aneuploidy | 1 | 2007 | 377 | 0.020 |
Why?
|
Adenoma | 1 | 2011 | 745 | 0.020 |
Why?
|
Acetylation | 1 | 2007 | 517 | 0.020 |
Why?
|
N-Myc Proto-Oncogene Protein | 1 | 2005 | 85 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2015 | 6211 | 0.020 |
Why?
|
Brain | 2 | 1996 | 4260 | 0.020 |
Why?
|
Anemia | 1 | 2011 | 730 | 0.020 |
Why?
|
Xenobiotics | 1 | 2005 | 43 | 0.020 |
Why?
|
Epithelium | 2 | 1998 | 805 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 895 | 0.020 |
Why?
|
Glycine | 1 | 2007 | 319 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2005 | 208 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2009 | 845 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2004 | 181 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2012 | 33909 | 0.020 |
Why?
|
Checkpoint Kinase 2 | 1 | 2005 | 131 | 0.010 |
Why?
|
Sampling Studies | 1 | 2004 | 171 | 0.010 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2004 | 85 | 0.010 |
Why?
|
Biological Evolution | 1 | 1985 | 293 | 0.010 |
Why?
|
In Vitro Techniques | 2 | 1999 | 1742 | 0.010 |
Why?
|
Genes, Suppressor | 1 | 2003 | 24 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2003 | 259 | 0.010 |
Why?
|
Transcription Factor Brn-3 | 1 | 2002 | 12 | 0.010 |
Why?
|
Transcription Factor Brn-3A | 1 | 2002 | 10 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 2841 | 0.010 |
Why?
|
Lung | 1 | 2014 | 3295 | 0.010 |
Why?
|
Doxycycline | 1 | 2003 | 178 | 0.010 |
Why?
|
Genetic Carrier Screening | 1 | 2003 | 101 | 0.010 |
Why?
|
Hydrogen Bonding | 1 | 2002 | 138 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 4352 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2003 | 185 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 855 | 0.010 |
Why?
|
Threonine | 1 | 2002 | 165 | 0.010 |
Why?
|
Philadelphia Chromosome | 1 | 2006 | 836 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2003 | 371 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2003 | 497 | 0.010 |
Why?
|
Retroviridae | 1 | 2003 | 376 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2002 | 212 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2002 | 154 | 0.010 |
Why?
|
Infant | 2 | 2011 | 13970 | 0.010 |
Why?
|
Risk Assessment | 2 | 2004 | 6885 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 2001 | 161 | 0.010 |
Why?
|
Caspase 3 | 1 | 2002 | 481 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 782 | 0.010 |
Why?
|
Galactose | 1 | 2001 | 79 | 0.010 |
Why?
|
Child, Preschool | 2 | 2011 | 17056 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2001 | 300 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2001 | 342 | 0.010 |
Why?
|
p21-Activated Kinases | 1 | 2001 | 132 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 582 | 0.010 |
Why?
|
Genetic Variation | 1 | 2008 | 2157 | 0.010 |
Why?
|
Lac Operon | 1 | 1999 | 135 | 0.010 |
Why?
|
SOX9 Transcription Factor | 1 | 2001 | 178 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2001 | 499 | 0.010 |
Why?
|
Caspases | 1 | 2002 | 687 | 0.010 |
Why?
|
Drug Design | 1 | 2001 | 378 | 0.010 |
Why?
|
Centromere Protein B | 1 | 1998 | 8 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 955 | 0.010 |
Why?
|
DNA, Satellite | 1 | 1998 | 44 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 39831 | 0.010 |
Why?
|
Cations | 1 | 1998 | 60 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1998 | 148 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2000 | 1143 | 0.010 |
Why?
|
Bronchial Neoplasms | 1 | 1998 | 83 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 347 | 0.010 |
Why?
|
DNA, Fungal | 1 | 1998 | 148 | 0.010 |
Why?
|
X-Rays | 1 | 1998 | 153 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 8612 | 0.010 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1998 | 190 | 0.010 |
Why?
|
Lactoglobulins | 1 | 1997 | 2 | 0.010 |
Why?
|
DNA, Viral | 1 | 1999 | 764 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2003 | 1351 | 0.010 |
Why?
|
Tretinoin | 1 | 1999 | 622 | 0.010 |
Why?
|
Mitotic Index | 1 | 1997 | 166 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 1997 | 407 | 0.010 |
Why?
|
Biological Transport | 1 | 1997 | 645 | 0.010 |
Why?
|
Liposomes | 1 | 1998 | 711 | 0.010 |
Why?
|
Bryostatins | 1 | 1995 | 14 | 0.010 |
Why?
|
Child | 2 | 2011 | 30559 | 0.010 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 1995 | 13 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1995 | 119 | 0.010 |
Why?
|
Gene Targeting | 1 | 1997 | 321 | 0.010 |
Why?
|
Macrolides | 1 | 1995 | 65 | 0.010 |
Why?
|
Testis | 1 | 1999 | 753 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 1997 | 674 | 0.010 |
Why?
|
Lactones | 1 | 1995 | 93 | 0.010 |
Why?
|
Cattle | 1 | 1997 | 846 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1998 | 1566 | 0.010 |
Why?
|
Retinoic Acid Receptor alpha | 1 | 1994 | 95 | 0.010 |
Why?
|
Glucose | 1 | 2001 | 1246 | 0.010 |
Why?
|
Liver Regeneration | 1 | 1995 | 134 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 7958 | 0.010 |
Why?
|
Carcinoma | 1 | 2004 | 2623 | 0.010 |
Why?
|
Hepatitis B | 1 | 1995 | 274 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 1998 | 1065 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 3176 | 0.010 |
Why?
|
Extremities | 1 | 1991 | 309 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1997 | 1443 | 0.010 |
Why?
|
Hepatectomy | 1 | 1995 | 1013 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1995 | 5107 | 0.000 |
Why?
|
Radioligand Assay | 1 | 1986 | 57 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1985 | 162 | 0.000 |
Why?
|
Trypsin | 1 | 1985 | 158 | 0.000 |
Why?
|
Procollagen | 1 | 1985 | 32 | 0.000 |
Why?
|
Tumor Virus Infections | 1 | 1986 | 249 | 0.000 |
Why?
|
Antigens, Viral | 1 | 1986 | 520 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2003 | 31066 | 0.000 |
Why?
|
Amino Acids | 1 | 1985 | 788 | 0.000 |
Why?
|
DNA, Recombinant | 1 | 1980 | 161 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1985 | 1327 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1980 | 735 | 0.000 |
Why?
|